
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.6B | $2.7B | $2.6B | $2.4B | $2.4B | |
Revenue Growth (YoY) | 1.52% | 2.05% | -3.12% | -9.44% | 1.25% | |
Cost of Revenues | $1.5B | $1.7B | $1.7B | $1.6B | $1.6B | |
Gross Profit | $1.1B | $1B | $888.2M | $789.5M | $785.5M | |
Gross Profit Margin | 41.51% | 37.73% | 34.2% | 33.57% | 32.99% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $886.7M | $625.2M | $607.2M | $635.4M | $650.3M | |
Operating Income | $203.7M | $386.2M | $281M | $154.1M | $135.2M | |
Net Interest Expenses | $1.6M | $1.4M | $436.9K | -- | -- | |
EBT. Incl. Unusual Items | $194.2M | $364.9M | $293.9M | $181.8M | $169.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $59.7M | $103.2M | $81.5M | $58.7M | $55.8M | |
Net Income to Company | $194.2M | $364.9M | $293.9M | $181.8M | $169.5M | |
Minority Interest in Earnings | -$34.7M | -$76.6M | -$55.4M | -$11M | -$7.4M | |
Net Income to Common Excl Extra Items | $99.7M | $185M | $157M | $112.1M | $106.4M | |
Basic EPS (Cont. Ops) | $0.50 | $0.94 | $0.79 | $0.57 | $0.54 | |
Diluted EPS (Cont. Ops) | $0.50 | $0.94 | $0.79 | $0.57 | $0.54 | |
Weighted Average Basic Share | $197.7M | $197.7M | $197.7M | $197.1M | $195.3M | |
Weighted Average Diluted Share | $197.7M | $197.7M | $197.7M | $197.1M | $195.3M | |
EBITDA | $281.7M | $450.6M | $371.3M | $262.4M | $253.3M | |
EBIT | $197.4M | $367.8M | $296.3M | $184.9M | $174.1M | |
Revenue (Reported) | $2.6B | $2.7B | $2.6B | $2.4B | $2.4B | |
Operating Income (Reported) | $203.7M | $386.2M | $281M | $154.1M | $135.2M | |
Operating Income (Adjusted) | $197.4M | $367.8M | $296.3M | $184.9M | $174.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $757.9M | $708.7M | $718.9M | $612.6M | $592.6M | |
Revenue Growth (YoY) | 10.37% | -6.49% | 1.43% | -14.79% | -0.23% | |
Cost of Revenues | $424.9M | $447.7M | $466.2M | $416.6M | $404M | |
Gross Profit | $333M | $261M | $252.7M | $196M | $188.7M | |
Gross Profit Margin | 43.94% | 36.83% | 35.15% | 31.99% | 31.84% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $223.8M | $155.7M | $144.4M | $160M | $160M | |
Operating Income | $109.2M | $105.3M | $108.3M | $36M | $28.7M | |
Net Interest Expenses | $833K | $730.1K | $610K | $1.8M | -- | |
EBT. Incl. Unusual Items | $110M | $107.8M | $110.6M | $56.1M | $37.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $33.7M | $28.3M | $33.1M | $17.3M | $15.8M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$13.9M | -$17.1M | -$19.3M | $1.1M | $3.7M | |
Net Income to Common Excl Extra Items | $62.3M | $62.4M | $58.3M | $39.9M | $25.7M | |
Basic EPS (Cont. Ops) | $0.32 | $0.32 | $0.29 | $0.20 | $0.13 | |
Diluted EPS (Cont. Ops) | $0.32 | $0.32 | $0.29 | $0.20 | $0.13 | |
Weighted Average Basic Share | $197.7M | $197.7M | $197.7M | $197.3M | $195.3M | |
Weighted Average Diluted Share | $197.7M | $197.7M | $197.7M | $197.3M | $195.3M | |
EBITDA | $110.8M | $108.6M | $111.2M | $56.9M | $38.8M | |
EBIT | $110.8M | $108.6M | $111.2M | $56.9M | $38.8M | |
Revenue (Reported) | $757.9M | $708.7M | $718.9M | $612.6M | $592.6M | |
Operating Income (Reported) | $109.2M | $105.3M | $108.3M | $36M | $28.7M | |
Operating Income (Adjusted) | $110.8M | $108.6M | $111.2M | $56.9M | $38.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.6B | $2.7B | $2.6B | $2.3B | $2.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.5B | $1.7B | $1.7B | $1.6B | $1.6B | |
Gross Profit | $1.1B | $1B | $885M | $789.2M | $794.9M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $886.7M | $623.9M | $607.3M | $634.2M | $658M | |
Operating Income | $205.1M | $386.4M | $277.7M | $154.9M | $136.9M | |
Net Interest Expenses | $1.6M | $1.4M | $392.1K | $1.1K | -- | |
EBT. Incl. Unusual Items | $195.5M | $365.2M | $291M | $182.3M | $171.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $60M | $103.4M | $80.5M | $58.7M | $56.4M | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$34.9M | -$76.6M | -$54.9M | -$11.1M | -$7.5M | |
Net Income to Common Excl Extra Items | $100.5M | $185.2M | $155.5M | $112.5M | $107.8M | |
Basic EPS (Cont. Ops) | $0.51 | $0.94 | $0.79 | $0.57 | $0.55 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.94 | $0.79 | $0.57 | $0.55 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $198.7M | $368.1M | $293.4M | $185.4M | $256.5M | |
EBIT | $198.7M | $368.1M | $293.4M | $185.4M | $176.3M | |
Revenue (Reported) | $2.6B | $2.7B | $2.6B | $2.3B | $2.4B | |
Operating Income (Reported) | $205.1M | $386.4M | $277.7M | $154.9M | $136.9M | |
Operating Income (Adjusted) | $198.7M | $368.1M | $293.4M | $185.4M | $176.3M |
Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2B | $1.9B | $1.8B | $1.1B | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $1.2B | $1.3B | $1.2B | $773.4M | -- | |
Gross Profit | $756.2M | $684.8M | $590.1M | $364.2M | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | -- | -- | -- | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $453.8M | $430.2M | $465.3M | $309.4M | -- | |
Operating Income | $302.3M | $254.6M | $124.9M | $54.8M | -- | |
Net Interest Expenses | $2.2M | $1.7M | $2.5M | $994.3K | -- | |
EBT. Incl. Unusual Items | $293.7M | $266.1M | $148.8M | $84.1M | -- | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $83.3M | $77.8M | $45.4M | $30M | -- | |
Net Income to Company | -- | -- | -- | -- | -- | |
Minority Interest in Earnings | -$56.4M | -$48.8M | -$5.9M | $4.7M | -- | |
Net Income to Common Excl Extra Items | $154M | $139.5M | $97.4M | $58.8M | -- | |
Basic EPS (Cont. Ops) | $0.78 | $0.71 | $0.49 | $0.30 | -- | |
Diluted EPS (Cont. Ops) | $0.78 | $0.71 | $0.49 | $0.30 | -- | |
Weighted Average Basic Share | $593.1M | $593.1M | $592.7M | $390.5M | -- | |
Weighted Average Diluted Share | $593.1M | $593.1M | $592.7M | $390.5M | -- | |
EBITDA | $295.9M | $267.9M | $150.9M | $86.2M | -- | |
EBIT | $295.9M | $267.9M | $150.9M | $86.2M | -- | |
Revenue (Reported) | $2B | $1.9B | $1.8B | $1.1B | -- | |
Operating Income (Reported) | $302.3M | $254.6M | $124.9M | $54.8M | -- | |
Operating Income (Adjusted) | $295.9M | $267.9M | $150.9M | $86.2M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $600.4M | $659.1M | $726.6M | $628.2M | $556.7M | |
Short Term Investments | $10.4M | -- | -- | -- | -- | |
Accounts Receivable, Net | $499.2M | $515M | $462.5M | $402.1M | $439M | |
Inventory | $445.3M | $595.2M | $502.1M | $469.4M | $550.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $104.5M | $134.2M | $121.3M | $120.4M | $94.3M | |
Total Current Assets | $1.7B | $1.9B | $1.8B | $1.6B | $1.6B | |
Property Plant And Equipment | $677.5M | $653.4M | $667.1M | $820.7M | $996.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $91.9M | $82.5M | $80.1M | $80.3M | $169M | |
Other Intangibles | $52.1M | $43.3M | $39.5M | $40.8M | $109.5M | |
Other Long-Term Assets | $20.6M | $17.9M | $142.9M | $17.8M | $21.6M | |
Total Assets | $2.8B | $3B | $3B | $2.9B | $3.2B | |
Accounts Payable | $149.4M | $171.8M | $163.4M | $147.4M | $160.8M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $113.1M | $165.2M | $172.4M | $246.2M | $206.2M | |
Total Current Liabilities | $510.1M | $648.5M | $506.2M | $532.9M | $490.7M | |
Long-Term Debt | $321.5M | $288.8M | $264.1M | $168M | $305.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $1.1B | $1.1B | $1B | $1.2B | |
Common Stock | $119.9M | $108.4M | $99.3M | $87.4M | $88.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $1.4B | $1.5B | $1.5B | $1.5B | $1.6B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $314.1M | $361.6M | $385.5M | $342.2M | $372.1M | |
Total Equity | $1.7B | $1.8B | $1.9B | $1.9B | $2B | |
Total Liabilities and Equity | $2.8B | $3B | $3B | $2.9B | $3.2B | |
Cash and Short Terms | $610.8M | $659.1M | $726.6M | $628.2M | $556.7M | |
Total Debt | $368.3M | $415.8M | $301M | $267.1M | $387.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $600.4M | $659.1M | $726.6M | $628.2M | $556.7M | |
Short Term Investments | $10.4M | -- | -- | -- | -- | |
Accounts Receivable, Net | $499.2M | $515M | $462.5M | $402.1M | $439M | |
Inventory | $445.3M | $595.2M | $502.1M | $469.4M | $550.2M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $104.5M | $134.2M | $121.3M | $120.4M | $94.3M | |
Total Current Assets | $1.7B | $1.9B | $1.8B | $1.6B | $1.6B | |
Property Plant And Equipment | $677.5M | $653.4M | $667.1M | $820.7M | $996.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $91.9M | $82.5M | $80.1M | $80.3M | $169M | |
Other Intangibles | $52.1M | $43.3M | $39.5M | $40.8M | $109.5M | |
Other Long-Term Assets | $20.6M | $17.9M | $142.9M | $17.8M | $21.6M | |
Total Assets | $2.8B | $3B | $3B | $2.9B | $3.2B | |
Accounts Payable | $149.4M | $171.8M | $163.4M | $147.4M | $160.8M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $113.1M | $165.2M | $172.4M | $246.2M | $206.2M | |
Total Current Liabilities | $510.1M | $648.5M | $506.2M | $532.9M | $490.7M | |
Long-Term Debt | $321.5M | $288.8M | $264.1M | $168M | $305.3M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1B | $1.1B | $1.1B | $1B | $1.2B | |
Common Stock | $119.9M | $108.4M | $99.3M | $87.4M | $88.4M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $314.1M | $361.6M | $385.5M | $342.2M | $372.1M | |
Total Equity | $1.7B | $1.8B | $1.9B | $1.9B | $2B | |
Total Liabilities and Equity | $2.8B | $3B | $3B | $2.9B | $3.2B | |
Cash and Short Terms | $610.8M | $659.1M | $726.6M | $628.2M | $556.7M | |
Total Debt | $368.3M | $415.8M | $301M | $267.1M | $387.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $194.2M | $364.9M | $293.9M | $181.8M | $169.5M | |
Depreciation & Amoritzation | $84.3M | $82.8M | $74.9M | $77.5M | $79.3M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -$11M | -$63.3M | $19.5M | $13.8M | $4.7M | |
Change in Inventories | -$6.5M | -$189.2M | $66.4M | $6.8M | -$33M | |
Cash From Operations | $255.6M | $145.9M | $336.8M | $202.2M | $106.1M | |
Capital Expenditures | $131.2M | $131.5M | $78.6M | $133.1M | $132.2M | |
Cash Acquisitions | -- | -- | -$7.9M | -$37.7M | -$156.5M | |
Cash From Investing | -$63.6M | -$92.6M | -$77.6M | -$138.5M | -$272.9M | |
Dividends Paid (Ex Special Dividend) | -$37.3M | -$36.9M | -$54.1M | -$52M | -$37.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $142.1M | $88.4M | $44.4K | $3.2M | $164.8M | |
Long-Term Debt Repaid | -$94.3M | -$489.9K | -$76.7M | -$727.6K | -$70.9M | |
Repurchase of Common Stock | -- | -- | -- | -$20.8M | -- | |
Other Financing Activities | -$14.5M | -$1.6M | -$12M | -$34.7K | -$39.4K | |
Cash From Financing | -$14.2M | $36.8M | -$164.5M | -$93.2M | $43M | |
Beginning Cash (CF) | $420.2M | $559.9M | $560.8M | $636.1M | $592.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $177.9M | $90.1M | $94.7M | -$29.5M | -$123.8M | |
Ending Cash (CF) | $593M | $674.6M | $679.7M | $625M | $494.2M | |
Levered Free Cash Flow | $124.4M | $14.4M | $258.2M | $69.1M | -$26.2M |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Period Ending | 2007-12-31 | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2011-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | $94.5M | -- | |
Depreciation & Amoritzation | -- | -- | -- | $52.8M | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -$17.4M | -- | |
Change in Inventories | -- | -- | -- | $7.1M | -- | |
Cash From Operations | -- | -- | -- | $120M | -- | |
Capital Expenditures | -- | -- | $27.8M | $32.5M | $11M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$117.3M | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$20.1M | -$21M | $871.1K | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -$14.1M | -- | |
Other Financing Activities | -- | -- | -- | $6.1M | -- | |
Cash From Financing | -- | -- | -- | $29.2M | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $31.9M | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | $87.5M | -- |
Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | -- | |
Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | -- | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -- | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -- | |
Cash From Financing | -- | -- | -- | -- | -- | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | -- | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | -- |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.